Advanced Cell Technology Inc. Message Board
-
If You Carefully Review Rabin's Presentation...
it would appear that he is setting up the stage for attracting would be and lucrative partnershipwhen the trials enter Phase III. His extended portion on Platelelets, emphasis on simplified and massive production of RPE cells from inexhaustible cell line using the blastomere technology requiring no destruction of embryo, definite signs of engrafment of RPE cells into the retina for both SMD and AMD patients even during this safety stage of the trials without any side effect and, finally, statement of having virtually all lawsuits ended are the cards he is placing on the table to attract prospective partners. Do not think those partners are not watching!! I expect, having seen the trading volume of last three sessions, that something has already begun in that direction.
Sentiment: Strong Buy
-
From LinkedIn:
Gary Rabin (Chairman and CEO of ACT) Advanced Cell Technology Achieves Clinical Milestone
Press Releases
Company is Halfway through Groundbreaking Clinical Trials; Evidence of Engraftment and Function Observed; No Safety Issues Reported MARLBOROUGH, Mass. — Jan. 8, 2013 – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC or the...Sentiment: Strong Buy
-
Good analysis yog!
I agree with you.- 1 Reply to blackmarango
-
It's ACTC. It won't happen. Still too much road to travel. 2.2 bil x .10 = 220 mil m cap ph 2 positive end 500 mil cap and then rev split talk. PPS at .067 and waiting to buy more after taking losses of yrs back.
-
Sounds about right to me.
Sentiment: Buy
-
If Rabin has any new information he should get it out tomorrow before the close. Today was typical sell on the news. Usually things are not as good as investors want to hear. Wishful thinking turns into wishful buying and when the truth comes out even if it is very, very good it is not able to meet the wishful thinking. This action can be thwarted by a constant string of news when least expected. Buyers over the last few days expected more than was or could be delivered.
- 2 Replies to easyesteemer
-
Easy, interesting and thoughtful reply.
Sentiment: Buy
-
Actually I meant to say before the open.
-
Profit taking today. A great number of people made about 35% on their money this last week, and I can't blame them for wanting to salt some away.
Sentiment: Strong Buy
- 1 Reply to ronbow502000
-
35% of what, unless they had a few million shares whatdid they profit. If they had held the stock would have gone higher and they would have made more. Chicken #$%$, i hope the stock goes up so fast and so much they cannot buy back without taking a loss.
Sentiment: Strong Buy
-
But, but, haven't you listened to "karen"? She/he says the chart points to .05 or lower! P&D, scam stock!
Just kidding, obviously! Thanks for the great synopsis! Amazing stuff, isn't it?- 1 Reply to minnesotafarmcountry
-
"it would appear that he is setting up the stage for attracting would be and lucrative partnershipwhen the trials enter Phase III. "
Sounds a lot like Karen,,,,that business about phase III. What phase are we in now, two years post-FDA approval?
We are midway phase I. This is why the deep pockets are not risking their millions by investing so early, just the retails (and the toxic financiers).
And we will visit .05s again IMO.
-